Literature DB >> 15564834

Auditory brainstem implantation in patients with neurofibromatosis type 2.

Seth J Kanowitz1, William H Shapiro, John G Golfinos, Noel L Cohen, J Thomas Roland.   

Abstract

OBJECTIVES: Multichannel auditory brainstem implants (ABI) are currently indicated for patients with neurofibromatosis type II (NF2) and schwannomas involving the internal auditory canal (IAC) or cerebellopontine angle (CPA), regardless of hearing loss (HL). The implant is usually placed in the lateral recess of the fourth ventricle at the time of tumor resection to stimulate the cochlear nucleus. This study aims to review the surgical and audiologic outcomes in 18 patients implanted by our Skull Base Surgery Team from 1994 through 2003. STUDY
DESIGN: A retrospective chart review of 18 patients with ABIs.
METHODS: We evaluated demographic data including age at implantation, number of tumor resections before implantation, tumor size, surgical approach, and postoperative surgical complications. The ABI auditory results at 1 year were then evaluated for number of functioning electrodes and channels, hours per day of use, nonauditory side effect profile and hearing results. Audiologic data including Monosyllable, Spondee, Trochee test (MTS) Word and Stress scores, Northwestern University Children's Perception of Speech (NU-CHIPS), and auditory sensitivity are reported.
RESULTS: No surgical complications caused by ABI implantation were revealed. A probe for lateral recess and cochlear nucleus localization was helpful in several patients. A range of auditory performance is reported, and two patients had no auditory perceptions. Electrode paddle migration occurred in two patients. Patient education and encouragement is very important to obtain maximum benefit.
CONCLUSIONS: ABIs are safe, do not increase surgical morbidity, and allow most patients to experience improved communication as well as access to environmental sounds. Nonauditory side effects can be minimized by selecting proper stimulation patterns. The ABI continues to be an emerging field for hearing rehabilitation in patients who are deafened by NF2.

Entities:  

Mesh:

Year:  2004        PMID: 15564834     DOI: 10.1097/01.mlg.0000149447.52888.f6

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  The inner ear and the neurologist.

Authors:  Charlotte Agrup; Michael Gleeson; Peter Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

2.  Primary auditory cortical responses to electrical stimulation of the thalamus.

Authors:  Craig A Atencio; Jonathan Y Shih; Christoph E Schreiner; Steven W Cheung
Journal:  J Neurophysiol       Date:  2013-12-11       Impact factor: 2.714

3.  Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.

Authors:  Pamela C Roehm; Jon Mallen-St Clair; Daniel Jethanamest; John G Golfinos; William Shapiro; Susan Waltzman; J Thomas Roland
Journal:  J Neurosurg       Date:  2011-07-15       Impact factor: 5.115

4.  Auditory brainstem implantation: The first Indian experience.

Authors:  Mohan Kameswaran; M C Vasudevan; R S Anand Kumar; Jawahar Nagasundaram; Kiran Natarajan; S Raghunandhan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-01

Review 5.  Clinical and scientific innovations in auditory brainstem implants.

Authors:  Kunal R Shetty; Sarah E Ridge; Vivek Kanumuri; Angela Zhu; M Christian Brown; Daniel J Lee
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2021-04-06

6.  Retrolabyrinthine approach for cochlear nerve preservation in neurofibromatosis type 2 and simultaneous cochlear implantation.

Authors:  Ricardo Ferreira Bento; Tatiana Alves Monteiro; Aline Gomes Bittencourt; Maria Valeria Schmidt Goffi-Gomez; Rubens de Brito
Journal:  Int Arch Otorhinolaryngol       Date:  2013-07

7.  Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06

Review 8.  Neurofibromatosis 2: hearing restoration options.

Authors:  Tatiana Alves Monteiro; Maria Valeria Schmidt Goffi-Gomez; Robinson Koji Tsuji; Marcos Queiroz Telas Gomes; Rubens Vuono Brito Neto; Ricardo Ferreira Bento
Journal:  Braz J Otorhinolaryngol       Date:  2012-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.